Understanding Glioma Diagnosis: How Doctors Use MRI and Pathology to Guide Treatment Options

“You can usually get a pretty good handle on the grade of the tumor by looking at how the tumor appears on MRI. Does it have a lot of enhancements? Is there a lot of swelling in edema?” Dr. Herbert Newton, a neuro-oncologist at UH Seidman Cancer Center in Cleveland, Ohio, tells SurvivorNet.

While MRI alone may not provide a definitive diagnosis, it offers crucial information about tumor characteristics that guide further evaluation and treatment planning.

How Does MRI Help Guide Treatment Decisions?

MRI scans provide detailed images that highlight different aspects of the tumor, including:

• Enhancement: Bright areas on the scan can indicate active tumor growth. The presence of contrast enhancement often suggests a high-grade glioma, meaning the tumor is more aggressive and may require intensive treatment.
• Swelling (Edema): Swelling around the tumor, known as edema, is caused by fluid buildup. This can contribute to symptoms such as headaches, nausea, and neurological deficits.
• Mass Effect: If the tumor exerts pressure on surrounding brain structures, it can lead to changes in function and increased symptoms. Understanding this impact helps doctors decide whether surgery is possible and necessary.

MRI Can Tell You if Your Tumor is Operable

The location of a glioma plays a critical role in determining whether it can be surgically removed. If a tumor is situated near vital areas of the brain, such as the brainstem or motor cortex, surgery may be too risky. In such cases, MRI helps neurosurgeons assess whether partial removal is possible or if other treatment options, such as radiation or chemotherapy, should be prioritized.

For some patients, surgical removal of the tumor can provide significant relief from symptoms and improve outcomes. However, in cases where complete removal is not possible, MRI remains an essential tool for monitoring the tumor and assessing the effectiveness of other treatments.

MRI is Used to Monitor Your Treatment Progress

Once treatment has begun, MRI scans are used regularly to track changes in the tumor. This helps doctors determine if therapies are working or if adjustments are needed.

Some key indicators include:

• Tumor Shrinkage: A decrease in size suggests that treatment is effective.
• Stability: If the tumor remains the same size without growth, the current treatment may be maintaining control.
• New Growth: If the tumor shows signs of expansion or new areas of enhancement appear, it may indicate tumor progression or recurrence, requiring a change in treatment strategy.

Regular MRI scans allow for early detection of changes, helping doctors tailor your treatment plan to achieve the best possible outcome.

Where Does Pathology Fit Into All of This?

While MRI provides critical information about the structure and behavior of a glioma, examining the tumor under a microscope remains the gold standard for diagnosis. After a biopsy or surgical removal, a pathologist examines the tumor to determine its grade, which directly impacts treatment decisions.

Gliomas are classified into different grades, 1 through 4, based on how aggressive they appear under the microscope.

Here’s a breakdown of each grade:

• Grade 1 (Pilocytic Astrocytoma): An indolent or very slow-growing tumor has the potential to return after surgery
• Grade 2 (Low-Grade Glioma): A slow-growing tumor that may eventually progress to a higher grade over time
• Grade 3 (Anaplastic Glioma): A more aggressive tumor that typically requires a combination of surgery, radiation, and chemotherapy
• Grade 4 (Glioblastoma): The most aggressive type, often requiring intensive treatment with surgery, radiation, and targeted therapies

Knowing the grade of your tumor helps your doctor decide on the most effective treatment approach.

The Role of Molecular Testing

In addition to traditional pathology, molecular testing has become increasingly important in glioma diagnosis and treatment. Advances in genetic and molecular research have led to the development of targeted therapies that can improve outcomes for some patients.

In glioma, your doctor may looks for several key markers, including:

• IDH Mutation: Tumors with an IDH mutation tend to have a better prognosis and respond well to certain therapies.
• 1p/19q Codeletion: Found in oligodendrogliomas, this marker is associated with better responses to chemotherapy and improved survival rates.
• MGMT Promoter Methylation: This determines whether a tumor is more likely to respond to temozolomide, a common chemotherapy drug for gliomas.
• EGFR Amplification and TERT Mutation: These are common in glioblastomas and may indicate more aggressive tumor behavior.

The Future of Treatment: Targeted Therapies

One exciting development in glioma treatment is the introduction of targeted drugs like vorasidenib. Vorasidenib is designed to specifically target IDH-mutant gliomas, offering a potential new treatment option for patients with this genetic mutation. Molecular testing helps identify whether a patient is a good candidate for this type of therapy, opening the door to more personalized treatment strategies.

Understanding your glioma and the tools used to diagnose and monitor it empowers you to make informed decisions about your care.

Here’s what you can do to take an active role in your treatment:

• Ask Questions: Make sure you understand the role of MRI, pathology, and molecular testing in your diagnosis.
• Request Regular Imaging: Keeping up with MRI scans allows for better monitoring of treatment progress.
• Discuss Molecular Testing: Ask your doctor if genetic testing is appropriate for your tumor.
• Explore All Treatment Options: Whether surgery, radiation, chemotherapy, or targeted therapies, knowing your options helps you make the best choice for your situation.

Questions to Ask Your Doctor

If you have been diagnosed with glioma and are confused about how treatment decisions are made, consider going to your doctor with the following questions.

• What did my MRI show?
• How often will I have to undergo MRIs during the treatment process?
• What is my grade?
• Which treatments, if any, should we consider after surgery?
• Can/should I undergo molecular testing?

Learn more about SurvivorNet's rigorous medical review process.

---